Division Director of Medical Oncology at Winship/Director Glenn Family Breast Center/Opinions=my own
Atlanta, Georgia
- Tweets 218
- Following 150
- Followers 2,364
- Likes 1,497
Kevin Kalinsky, MD, MS, FASCO retweeted
I am proud to support @DrDawnHershman @columbiacancer for @ASCO Board of Directors. Her research has transformed how we care for patients with breast cancer, and she is Co-Chair of @SWOG. She is the most generous mentor I know and will represent us well. Please vote. Vision and video here - asco.org/about-asco/asco-ove…
5
25
1,200
Proud to support @DrDawnHershman for the ASCO Board. She is an extraordinary mentor, generous with her time and invested in the success of everyone around her. The most productive person I know. She would be a tremendous addition. #bcsm #onctwitter @SWOG
I am running for the ASCO Board out of a deep commitment to an organization that has shaped my career. A belief that through collective engagement & shared leadership, we can expand opportunities, inform policy, advance care, and improve the lives of all people with cancer,
2
16
633
Kevin Kalinsky, MD, MS, FASCO retweeted
📢 #ESMO26 concomitant paper: OS from the phase 3 postMONARCH trial of abemaciclib + fulvestrant vs pbo + fulvestrant for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor + endocrine therapy.
🔗tinyurl.com/mt82dufd
@KalinskyKevin @BianchiniGP
18
32
2,496
Kevin Kalinsky, MD, MS, FASCO retweeted
Coming up this week! Join us Sept. 19 for the Atlanta Breast Cancer Conference, co-chaired by Winship experts Kevin Kalinsky, MD, MS; Tari King, MD; and Reshma Jagsi, MD, DPhil.
There’s still time to register! Learn more ➡️ bioascend.com/atlanta-breast
1
3
9
919
Team effort! @SWOG @WinshipAtEmory
🆕article in press: Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER) @KalinskyKevin
3
13
1,905
Looking forward to this meeting!
Our 5th Annual National General Medical Oncology Summit will be a one-of-a-kind offering, featuring a multidisciplinary faculty of clinical investigators and a blend of short presentations, lively moderated panel discussions and dedicated Q&A. Register: researchtopractice.com/Meeti…
4
2
6
880
Kevin Kalinsky, MD, MS, FASCO retweeted
.@eaonc is hosting a webinar on EA1241, a companion study for pts previously enrolled in TAILORx or RxPONDER. Investigators & #ClinicalResearch professionals are invited to register below.
📅Feb 4 | 4 PM ET
🎙 @jsparano, @KalinskyKevin, @RimapatelMD
🔗bit.ly/EA1241webinar
3
2
1,075
Join me at the 43rd Annual Miami Breast Cancer Conference! I'll be sharing insights alongside top experts to advance breast cancer care. Use my last name discount code for FREE registration. Register today: gotoper.com/mbccfof #MBCC25 #BreastCancerCare #BCSM
290
Kevin Kalinsky, MD, MS, FASCO retweeted
#ClinicalTrial EA1241 is evaluating tissue samples from past TAILORx & RxPONDER trial participants who experienced a recurrence. This research aims to uncover why #BreastCancer returns after treatment. bit.ly/EA1241 cc: @jsparano, @KalinskyKevin, @RimapatelMD
1
1
241
Kevin Kalinsky, MD, MS, FASCO retweeted
#ClinicalTrial EA1241 is evaluating tissue samples from past TAILORx & RxPONDER trial participants who experienced a recurrence. This research aims to uncover why #BreastCancer returns after treatment. bit.ly/EA1241 cc: @jsparano, @KalinskyKevin, @RimapatelMD
1
3
313
Kevin Kalinsky, MD, MS, FASCO retweeted
From #ASH —> #SABCS25! Look forward to seeing how this is going to change/inform our practice in breast cancer!!
In Person: Dec 10, 2025
⏰ Time: 7-9PM
✅ Register here: bit.ly/aiosabcs25
#OncTwitter #MedTwitter #bcsm #AdvInOnc25 @OncUpdates @OncoAlert
2
14
40
9,321
Kevin Kalinsky, MD, MS, FASCO retweeted
Trial Activation: EA1241, led by @jsparano of @MountSinaiNYC, is a companion study for patients who previously took part in either the TAILORx or RxPONDER #BreastCancer trials. For more information: bit.ly/EA1241 cc: @KalinskyKevin, @RimapatelMD
2
3
312
Kevin Kalinsky, MD, MS, FASCO retweeted
Getting ready for @OncLive #BTGBreast25 tomorrow. Let's do some polling questions! #MJHLifeSciences @jhaveri_komal @KalinskyKevin @Neil_Iyengar @JAMouabbi
When considering de-escalation in HER2+ early breast cancer, which factor most influences your decision?
16%
Residual disease burden
47%
pCR + clinical features
11%
Genomic risk scores
26%
Toxicity concerns
19 votes • Final results
4
8
1,222
Kevin Kalinsky, MD, MS, FASCO retweeted
Getting ready for @OncLive #BTGBreast25 tomorrow. Let's do some polling questions! #MJHLifeSciences @jhaveri_komal @KalinskyKevin @Neil_Iyengar @JAMouabbi
Are TIL levels currently influencing your treatment decisions in #TNBC in clinical practice? #breastcancer
21%
Routinely considered
26%
Sometimes considered
26%
Rarely/only in trials
26%
Not yet incorporated
19 votes • Final results
7
6
1,467
Kevin Kalinsky, MD, MS, FASCO retweeted
In this episode of 5-Minute Journal Club, Dr Neil Love is joined by Dr Kevin Kalinsky to define the future role of TROP2-directed antibody-drug conjugates in breast cancer. Watch or listen here: ow.ly/5R5W50X4iy9
1
6
357
Kevin Kalinsky, MD, MS, FASCO retweeted
We kick-off the inaugural Atlanta Breast Cancer Conference with @KalinskyKevin welcoming attendees to discuss the care of multiple breast cancer subtypes.
#AtlBreast25
1
1
2
225
Kevin Kalinsky, MD, MS, FASCO retweeted
Still time to register! Join our esteemmed faculty @EmoryUniversity @WinshipAtEmory Updates in #HNCA acrobat.adobe.com/id/urn:aai… on September 6th; @StokedStokes @NikkiSchmittMD @ConorSteuerMD
3
10
647
Kevin Kalinsky, MD, MS, FASCO retweeted
Absolutely outstanding breast cancer session at #DDHO2025. Major themes included treatment de-escalation strategies, adjuvant advances making cure even more possible, and of course lifestyle guidance. I am so incredibly excited to join the remarkable team at @WinshipAtEmory
2
5
35
2,136
Kevin Kalinsky, MD, MS, FASCO retweeted
The Glenn Family Breast Cancer Center invites you to the Inaugural Atlanta Breast Cancer Conference on Saturday, September 27, 2025. Learn more and register at bioascend.com/atlanta-breast…
#ATLBreast25
1
9
770
Kevin Kalinsky, MD, MS, FASCO retweeted
📅 Join us tomorrow for our, Expert Analysis of the Top Abstracts From the 2025 Oncology Meeting.
We’re bringing timely, expert-led insights straight to your practice.
✅ Practical strategies for patient care
✅ Designed for oncologists and cancer care teams
✅ CME-accredited
Don’t miss it—register now and be part of the conversation with,
@FordePatrick, @KalinskyKevin, @stolaney1
Register: bit.ly/45H9vwt
2
7
804